Liu JH - Search Results

1

ATP citrate lyase inhibitors as novel cancer therapeutic agents.

Zu XY, Zhang QH, Liu JH, Cao RX, Zhong J, Yi GH, Quan ZH, Pizzorno G. Zu XY, et al. Among authors: liu jh. Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):154-67. doi: 10.2174/157489212799972954. Recent Pat Anticancer Drug Discov. 2012. PMID: 22339355 Review.

2

Small interfering RNA-mediated caveolin-1 knockout on plasminogen activator inhibitor-1 expression in insulin-stimulated human vascular endothelial cells.

Yang H, He S, Quan Z, Peng W, Yan B, Liu J, Wen F, Cao R, Xu Y, Wen G, Hu W. Yang H, et al. Acta Biochim Biophys Sin (Shanghai). 2007 Mar;39(3):224-33. doi: 10.1111/j.1745-7270.2007.00270.x. Acta Biochim Biophys Sin (Shanghai). 2007. PMID: 17342262 Free article.

3

Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.

Liu J, Wen G, Cao D. Liu J, et al. Recent Pat Anticancer Drug Discov. 2009 Nov;4(3):246-53. doi: 10.2174/157489209789206931. Recent Pat Anticancer Drug Discov. 2009. PMID: 19522700 Review.

4

Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer.

Zhong J, Cao RX, Hong T, Yang J, Zu XY, Xiao XH, Liu JH, Wen GB. Zhong J, et al. Among authors: liu jh. Gene. 2011 Nov 1;487(1):1-9. doi: 10.1016/j.gene.2011.06.022. Epub 2011 Jul 18. Gene. 2011. PMID: 21820040

5

Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update.

Zu X, Zhang Q, Cao R, Liu J, Zhong J, Wen G, Cao D. Zu X, et al. Cell Tissue Res. 2012 Jan;347(1):73-84. doi: 10.1007/s00441-011-1225-3. Epub 2011 Aug 16. Cell Tissue Res. 2012. PMID: 21845401 Review.

6

Adiponectin protects endothelial cells from the damages induced by the intermittent high level of glucose.

Xiao X, Dong Y, Zhong J, Cao R, Zhao X, Wen G, Liu J. Xiao X, et al. Endocrine. 2011 Dec;40(3):386-93. doi: 10.1007/s12020-011-9531-9. Epub 2011 Sep 24. Endocrine. 2011. PMID: 21948177

7

Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma.

Zhong J, Cao RX, Zu XY, Hong T, Yang J, Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH, Wen GB. Zhong J, et al. Among authors: liu l, liu jh. FEBS J. 2012 Jan;279(2):316-35. doi: 10.1111/j.1742-4658.2011.08426.x. Epub 2011 Dec 9. FEBS J. 2012. PMID: 22093364 Free article.

8

Editorial: anti-lipogenesis as a novel strategy for cancer therapy.

Liu J, Cao D. Liu J, et al. Recent Pat Anticancer Drug Discov. 2012 May 1;7(2):149-53. doi: 10.2174/157489212799972936. Recent Pat Anticancer Drug Discov. 2012. PMID: 22338611 No abstract available.

9

An involvement of SR-B1 mediated PI3K-Akt-eNOS signaling in HDL-induced cyclooxygenase 2 expression and prostacyclin production in endothelial cells.

Zhang QH, Zu XY, Cao RX, Liu JH, Mo ZC, Zeng Y, Li YB, Xiong SL, Liu X, Liao DF, Yi GH. Zhang QH, et al. Among authors: liu x, liu jh. Biochem Biophys Res Commun. 2012 Mar 30;420(1):17-23. doi: 10.1016/j.bbrc.2012.02.103. Epub 2012 Feb 27. Biochem Biophys Res Commun. 2012. PMID: 22390933

10

AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.

Ma J, Luo DX, Huang C, Shen Y, Bu Y, Markwell S, Gao J, Liu J, Zu X, Cao Z, Gao Z, Lu F, Liao DF, Cao D. Ma J, et al. Int J Cancer. 2012 Sep 15;131(6):E862-71. doi: 10.1002/ijc.27618. Epub 2012 May 21. Int J Cancer. 2012. PMID: 22539036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,318 results

Search Page

Filters